Basal Insulin Therapy in the Treatment of Insulin Resistant Type 2 Diabetes: The Role of the Pharmacist in Ensuring the Safe and Effective Use in Patients
Date & Time: Please note, revised schedule!Thursday, April 30, 2015
6:00 pm - 6:30 pm Registration and Appetizers
6:30 pm - 7:00 pm Dinner
7:00 pm - 8:00 pm Program
Location:Maggiano’s Little Italy240 Oakbrook Center
Oak Brook, IL 60523
(630) 368-0300
Overview:This program will focus on the use of high concentration insulin formulations in the treatment of type 2 diabetes. Faculty will discuss the clinical, pharmacokinetic and pharmacodynamic profiles for current and emerging basal insulins as well as currently available insulin pens and syringes used for the administration of insulin. Additionally, faculty will provide instruction regarding strategies for safely converting between U-100 and concentrated insulin formulations using different syringes and pen devices.
Target Audience:This activity has been developed for pharmacists, pharmacy directors, and other healthcare professionals involved in the management of patients with diabetes.
Learning Objectives:- Describe the reasons for the use of high concentration insulin formulations in the treatment of type 2 diabetes
- Discuss the clinical, pharmacokinetic and pharmacodynamic profiles for current and emerging basal insulins
- Implement strategies for safely converting between U-100 and concentrated insulin formulations using different syringes and pen devices in patients with type 2 diabetes
- Review currently available insulin pens and syringes used for the administration of insulin
- Explain and apply strategies to overcome the barriers to insulin-mediated glucose control
Faculty: Susan Cornell, BS, Pharm.D., CDE, FAPhA, FAADE
Associate Professor of Pharmacy Practice
Midwestern University Chicago College of Pharmacy
Downers Grove, IL
Continuing Education Credits: To receive continuing education credit for this program, participants must attend the conference, complete the Pre- and Post-Activity ARS surveys, and submit an activity evaluation which will be provided to you via email following the live activity. Once your evaluation is received statements of credit will be uploaded to participant NABP e-profiles via CPE Monitor within 30 days of completion of the program. Paper statements will not be mailed. These are ongoing programs with an initial release date of 04.24.15.
Accreditation: The University of the Pacific, Thomas J. Long School of Pharmacy and Health Sciences is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This program is accredited for a maximum of 1.0 hours of continuing education credit (0.1 CEU) for pharmacists and is numbered 0006-0000-15-013-L01-P.
This program provided by University of the Pacific and Horizon CME.
This Educational Program is being supported by Sanofi US.
Registration: Sorry, registration is now closed. Registration deadline is Monday, April 27th at 9:00 am.
This program is free to ICHP members. However, those who do not attend and do not cancel at least 48 hours prior to the program will be charged $50.00 to cover expenses. Pre-registration is required. Please bring a copy of your email registration confirmation with you to the meeting.
